Dosage forms and related therapies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/30 (2006.01) A61K 31/132 (2006.01) A61P 3/10 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2496411

This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogues, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.

Cette invention concerne, en partie, de nouvelles doses et formes posologiques, et des modes d'administration desdites doses et formes posologiques contenant un ou plusieurs chélateurs du cuivre, par exemple une ou plusieurs substances actives de trientine, y compris des analogues de trientine, des sels de trientine, des promédicaments de trientine, et des dérivés de trientine, utiles dans le traitement de maladies, troubles ou pathologies, notamment dans des indications où le cuivre peut jouer un rôle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dosage forms and related therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage forms and related therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage forms and related therapies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1402406

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.